Royalty Pharma plc (RPRX) Profit Margins
Over the twelve months to 2026-06-30, Royalty Pharma plc (RPRX) had operating margin 59.6%, net margin 32.1%, free cash flow margin 117.4%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
RPRXRoyalty Pharma plcFollow RPRX — free
—
Price chart with a free account
- Market cap
- 36.7B
- P/E TTM
- 34.0
- Dividend yield
- 1.1%
- 52-week
- —
- Next earnings
- 4 Nov, in 11 days
| Line | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 85.0% | 79.2% | 31.8% | 76.2% | 67.6% | — | — | |
| Operating margin | 75.2% | 62.5% | 13.7% | 63.4% | 57.1% | 65.6% | 59.6% | |
| Net margin | 45.9% | 27.1% | 1.9% | 48.2% | 37.9% | 32.4% | 32.1% | |
| FCF margin | — | — | — | — | 122.3% | 104.7% | 117.4% |
USD billions · SEC XBRL
Royalty Pharma plc — questions
- What is Royalty Pharma plc's operating margin?
- 59.6% over the twelve months to 2026-06-30.
- What is Royalty Pharma plc's net profit margin?
- 32.1% over the twelve months to 2026-06-30.
Every figure on this page comes from Royalty Pharma plc's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.